Healthy Life Agritec Ltd has received board approval to raise up to Rs 50 crore through a rights issue of partly paid-up equity shares. A dedicated committee has been formed to finalize the pricing, record date, and entitlement ratio, which remain pending. This capital infusion move signals the company's intent to boost its financial runway, though shareholders must await further disclosures regarding the specific offer terms and payment structure.
Healthy Life Agritec Approves Rs 50 Crore Rights Issue
Healthy Life Agritec Ltd board approves Rs 50 crore fundraising plan via rights issue. The issuance will consist of partly paid-up equity shares with a face value of Rs 10 each.
Reader Takeaway: Company targets capital infusion, but final impact hinges on pricing and entitlement ratio yet to come.
What just happened
The board of Healthy Life Agritec Ltd met on September 23, 2026, to authorize a capital-raising exercise. The company will issue shares via a rights issue, capped at Rs 50 crore (Rs 5,000 lakh). To ensure seamless execution, the company has constituted a Rights Issue Committee comprising Divya Mojjada (Chairperson), Mohammed Sadiq, and Apra Sharma.
Why this matters
This move allows existing shareholders to participate in the company’s growth by subscribing to additional shares. Because the proposed shares are 'partly paid-up,' investors should anticipate a structure where the full payment is not due upfront, but rather called in stages. This can be a capital-efficient way for the company to raise funds, but it leaves an ongoing obligation for the participating shareholder.
What changes now
For now, the board has only established the intent and the maximum quantum. All critical details, such as the issue price, the specific ratio of entitlement (how many shares an existing holder can buy), and the record date to determine eligibility, are still being finalized. The company must obtain further regulatory clearances per SEBI ICDR guidelines before launching the offer.
What to track next
Investors should closely monitor the next BSE filing for the Rights Issue Committee’s determination on the issue price and timeline. The record date will be the most significant milestone for existing shareholders, as it dictates who is eligible to participate in the offering.